UCHL1 is a Parkinson's disease susceptibility gene
Demetrius M. Maraganore(Tulane University), Walter A. Rocca(Mayo Clinic), Aldo Quattrone(Magna Graecia University), Taksushi Toda(The University of Osaka), Marie‐Christine Chartier‐Harlin(Inserm), Mariza de Andrade(Mayo Clinic), Timothy G. Lesnick(Mayo Clinic in Florida), Alexis Elbaz(Inserm), Thomas Gasser(Hertie Institute for Clinical Brain Research), John P. A. Ioannidis(Innovative Research (United States)), Jian Wang(Wenzhou Medical University), Jun‐ichi Satoh(Meiji Pharmaceutical University), George D. Mellick(Griffith University), Rejko Krüger(Centre Hospitalier de Luxembourg), Nobutaka Hattori(Juntendo University Hospital)
Cited by 266
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
|Nature Reviews Genetics|2008|3k
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k